Financial Performance

The unification of Performive and CloudFirst creates a managed services leader targeting complex enterprise IT with expanded security, DRaaS, and IBM Power solutions.

With most Arizonans needing addiction or mental health care not receiving it, one provider is launching a new plan to dismantle barriers and improve access.

Global hygiene firm Essity sees a contentious bondholder lawsuit discontinued with no compensation paid, closing a chapter that tested corporate debt covenants.

The firm is now recruiting for a Phase 1 trial of HWK-007 and has submitted an IND for HWK-016, targeting tough lung, ovarian, and endometrial cancers.

Frontier Airlines appoints decade-long veteran James Dempsey as its new CEO and raises its Q4 earnings outlook, signaling operational resilience.

At CES 2026, Hitachi unveiled major AI alliances with NVIDIA and Google, betting its HMAX platform can embed intelligence into the world's core systems.

A new partnership leverages in vivo screening to find novel obesity targets, aiming to revolutionize a market projected to exceed $100 billion.

The National Retail Federation partners with Insider One, using advanced AI to personalize its massive 2026 trade show for 40,000 attendees.

Targa Exploration grows its El Zanjon project by 66% in a key gold district, signaling a major push to uncover a new discovery in Santa Cruz.

With a potential winter drill program at its Tharsis REE project and high-grade results at Big Mack, the company is advancing two key Canadian assets.

With an expanded Boehringer Ingelheim deal and a new CMO, Enara Bio is set to take its novel 'Dark Antigen' therapy into human trials in 2026.

A looming 10-million-ton copper deficit threatens to derail the AI revolution and the green energy transition, sparking a new era of geopolitical competition.

Eurythmics legend Dave Stewart launches a new venture builder to give artists control over their IP and revenue. But can this "creativity-first" model work?

Rani Therapeutics starts Phase 1 trials for an oral obesity drug, challenging the injectable market with a novel delivery system and a dual-action compound.

The UK charity is launching The Waqf Fund, blending ancient Islamic finance with modern investment to create a self-sustaining model for global aid.

The NBA partners with broker STARTRADER in a multi-year deal, signaling a major push into the Middle East and a new playbook for FinTech branding.

A $10 billion fund. Two competing visions. Wingspan Advisors' unique 'Alpha Summit' will decide the future of its ambitious new investment vehicle.

A landmark deal brings a leading U.S. venue management platform to Japan, South Korea, and Taiwan, aiming to transform fan safety and operations.

A newly validated genetic test accurately predicts melanoma risk, offering a non-invasive alternative to the standard surgical biopsy for many patients.

After success in Europe, Allotex gets FDA nod to begin U.S. trials for its tissue-based presbyopia treatment, offering new hope for millions.